[ad_1] Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys…
Tag:
Novartis AG ADR
-
-
STOCK MARKET
It’s shaping up to be a great quarter for Europe’s biggest companies — no thanks to Europe.
by userby user[ad_1] Fourth-quarter earnings season in Europe is still in its early days, but the largest…
-
STOCK MARKET
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
by userby user[ad_1] UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of…
-
STOCK MARKET
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
by userby user[ad_1] Shares of Cabaletta Bio Inc. CABA, Gracell Biotechnologies Inc. GRCL and other smaller biotech…
-
STOCK MARKET
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
by userby user[ad_1] Fixes story to correct spelling of analyst’s name. The trial success of Novo Nordisk’s…
-
STOCK MARKET
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
by userby user[ad_1] Medicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation…
-
STOCK MARKET
Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal
by userby user[ad_1] Shares of Bausch + Lomb Corp. leapt into record territory Friday, after the eye-health…
-
STOCK MARKET
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
by userby user[ad_1] Here are some of the biggest movers of Monday. Stock gainers: Biogen Inc. shares…
-
STOCK MARKET
First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial
by userby user[ad_1] Here were some of the most active stocks in premarket trade, as U.S. stock…
-
STOCK MARKET
This chart offers one reason that European stocks may continue to outperform U.S. equities
by userby user[ad_1] One of the stories for markets this year has been the outperformance of European…
- 1
- 2